Moise L Levy
Overview
Explore the profile of Moise L Levy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
633
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boguniewicz M, Levy M, Eichenfield L, Lauren C, Leung D, Schneider L, et al.
J Pediatr Clin Pract
. 2025 Feb;
14:200121.
PMID: 39950052
Objective: This expert-led consensus aims to provide primary care providers (PCPs) with recommendations for the care of atopic dermatitis (AD) in patients aged <18 years. The first point of contact...
2.
Pathmarajah P, Eid E, Nazaroff J, So J, Mittal V, Harris N, et al.
Br J Dermatol
. 2025 Jan;
PMID: 39790012
Recessive dystrophic epidermolysis bullosa (RDEB) is a genetic disorder due to pathogenic variants in the COL7A1 gene. In this study we determined the association between different categories of COL7A1 variants...
3.
Castro Porto Silva Lopes F, Schroeder C, Patel B, Levy M
Semin Pediatr Neurol
. 2024 Dec;
52:101166.
PMID: 39622606
Encephalocraniocutaneous lipomatosis (ECCL), also known as Haberland syndrome, is a sporadic tumor predisposition neurocutaneous disorder, included in the oculoectodermal syndrome group of mosaic RASopathies. ECCL primarily affects the skin, central...
4.
Nguyen C, Haller C, Brichta L, Paller A, Levy M
Pediatr Dermatol
. 2024 Nov;
41(6):1253-1254.
PMID: 39563627
No abstract available.
5.
Eichenfield L, Boguniewicz M, Lauren C, Leung D, Levy M, Schneider L, et al.
Dermatology
. 2024 Oct;
240(5-6):897-909.
PMID: 39406204
Atopic dermatitis (AD) is a chronic, type-2 mediated, inflammatory skin disease characterized by intense pruritus, disruption of skin barrier function, and immune dysregulation. Management strategies for AD are routinely determined...
6.
Perez V, Mulinda C, Bruckner A, Diaz L, Hook K, Lara-Corrales I, et al.
Pediatr Dermatol
. 2024 Sep;
41(6):1117-1120.
PMID: 39235093
The characteristics of epidermolysis bullosa (EB) demand higher than average provider support for transition from pediatric to adult care. We administered an online Qualtrics survey to members of the Epidermolysis...
7.
Nguyen C, Haller C, Levy M
Pediatr Dermatol
. 2024 Aug;
42(1):180-181.
PMID: 39155550
No abstract available.
8.
Paladichuk H, Shivaprakash N, Haller C, Diaz L, Wilkinson M, Levy M, et al.
Dermatol Online J
. 2024 Jul;
30(2).
PMID: 38959916
Emergency department visits and healthcare expenditures for pediatric atopic dermatitis have been increasing over the last two decades. There is a paucity of replicable quality improvement initiatives addressed at educating...
9.
Molnar B, Levin L, Yun D, Morel K, Wiss K, Wieser J, et al.
J Am Acad Dermatol
. 2024 Apr;
91(2):290-299.
PMID: 38604489
Background: Epidermolysis bullosa (EB), characterized by skin fragility and blistering, often requires hospitalization. Training for inpatient management of EB is limited, with no unified recommendations available in North America. Objective:...
10.
Fanous N, Clarke E, Levy M
Pediatr Dermatol
. 2024 Feb;
41(4):728-730.
PMID: 38368940
IgA vasculitis (IgAV), formerly known as Henoch-Scholein purpura, is a small vessel vasculitis, most commonly seen in pediatric patients, that can affect numerous internal organs including the kidneys, lungs, gastrointestinal...